USPTO serial 76340073
MYOGUARD
Reviewed by CopyMark Law Group
Status 601
- Filing date
- Status date
- Registration date
- —
- Examiner
- GARNER, CHRISTINA
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MYOGUARD?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
2333 CN Leiden, Nederland, NL
2333 CN Leiden, Nederland, NL
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lawrence E. Abelman
LAWRENCE E ABELMAN ABELMAN FRAYNE & SCHWAB150 E 42ND STNEW YORK, NY 10017-5612UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for medical, therapeutic and/or prophylactic use in the treatment and/or prevention of defects to the central nervous system and/or the peripheral nervous system; and diagnostic preparations for clinical or medical laboratory use | ACTIVE | — |
| 040 | Treatment of protein-like substances, namely, chemical treatment for medical use, research or diagnostic purposes; treatment of protein-like substances with characteristics that have a positive influence on the treatment and/or prevention of defects to the central nervous system and/or the peripheral nervous system, namely, chemical treatment for others | ACTIVE | — |
| 042 | Scientific research of protein-like substances with characteristics that have a positive influence of the treatment and/or prevention of defects to the central nervous system and/or the peripheral nervous system; and research, namely, scientific, chemical and medical research and testing of protein-like substrances with characteristics that have a positive influence on the treatment and/or prevention of defects to the central nervous system and/or the peripheral nervous system for diagnostic purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Crucell Holland B.V.
- Other trademarks owned by Crucell Holland B.V.
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named MYOGUARD
- Prosecution event NOAM explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 11, 2003 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 6, 2003 | PAPER RECEIVED | — | |
| Jan 2, 2003 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| Nov 19, 2002 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 30, 2002 | NPUB | NOTICE OF PUBLICATION | — |
| Sep 16, 2002 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 11, 2002 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Aug 8, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 8, 2002 | PAPER RECEIVED | — | |
| Feb 7, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 1, 2002 | DOCK | ASSIGNED TO EXAMINER | — |